Prev Arrow Stocks

Quidelortho Corpoation ($QDEL) Stock Forecast: Down 7.1% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Quidelortho Corpoation?

Quidel Corporation (QDEL) is a company specializing in diagnostic healthcare solutions, including rapid diagnostic testing.

Why is Quidelortho Corpoation going down?

QDEL stock is down 7.1% on Apr 10, 2025 18:04

  • The surge in QDEL's stock price might have been driven by the positive sentiment surrounding its strong product portfolio.
  • However, the bearish movement today could be attributed to profit-taking by investors after a significant surge.
  • The uncertainty regarding the stock's ability to sustain further gains due to the latest trend in earnings estimate revisions might have also contributed to the bearish movement.
  • Overall, while QDEL has shown growth potential, short-term fluctuations in the market sentiment and earnings outlook can lead to bearish movements like the one observed today.

QDEL Price Chart

QDEL Technical Analysis

QDEL News

QuidelOrtho ( QDEL ) Surges 10.1%: Is This an Indication of Further Gains?

QuidelOrtho (QDEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

https://www.zacks.com/stock/news/2444135/quidelortho-qdel-surges-101-is-this-an-indication-of-further-gains

0 Missing News Article Image QuidelOrtho  ( QDEL )  Surges 10.1%: Is This an Indication of Further Gains?

Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now

QDEL continues to witness growth on the back of its strong product portfolio.

https://www.zacks.com/stock/news/2442848/reasons-to-retain-quidelortho-stock-in-your-portfolio-for-now

1 Missing News Article Image Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now

Quidelortho Corpoation Price History

08.10.2024 - QDEL Stock was up 11.3%

  • QDEL's strong bullish movement today is due to the company surpassing Q3 earnings and revenue estimates by a notable margin.
  • An earnings surprise of 174.19% and a revenue surprise of 12.75% have probably increased investor confidence in the company's performance.
  • This favorable financial report suggests promising growth opportunities for QDEL, potentially attracting more investor attention and driving up the stock price during today's trading session.

08.10.2024 - QDEL Stock was up 12.5%

  • QDEL stock experienced a strong bullish movement today.
  • The company reported impressive third-quarter earnings and revenue results, surpassing analyst estimates by a significant margin.
  • Despite a decline in gross margin, the growth in non-respiratory revenues and cost-cutting measures contributed to the positive performance.
  • Investors are optimistic about QDEL's future prospects as the company continues to outperform expectations and demonstrate resilience in a challenging market environment.

22.10.2024 - QDEL Stock was up 5.1%

  • Quidel's stock experienced a strong bullish movement today despite significant shares being sold in an underwritten secondary offering.
  • The positive market sentiment towards Quidel could be attributed to the company not selling any shares itself, indicating confidence in its current position and future prospects.
  • Additionally, the bearish movement of Powell Industries (NASDAQ: POWL) due to weak sales could have led investors to shift their focus towards Quidel, viewing it as a more promising investment option in the healthcare sector.
  • Overall, Quidel's resilience in the face of external selling pressure and the contrast with Powell Industries' performance likely contributed to its bullish movement today.

05.08.2024 - QDEL Stock was up 5.2%

  • The bullish movement in QDEL's stock price today is linked to the FDA's approval of its new VITROS syphilis assay, which broadens its range of infectious disease testing options.
  • Investor optimism may also be contributing to this positive trend, stemming from the company's recent earnings report that highlighted its performance and growth potential.
  • The combined effect of the new product clearance and promising financial outlook is likely boosting investor confidence in QDEL, leading to the stock's strong upward movement.

13.10.2024 - QDEL Stock was down 6.2%

  • Despite beating earnings and revenue estimates in Q3, QDEL stock saw a strong bearish movement, indicating that the market may have had different expectations.
  • The rise in AirSculpt Technologies (NASDAQ:AIRS) and the warning about potential plunging health care stocks could have influenced investor sentiment towards QDEL.
  • The decline in gross margin in Q3, despite the positive revenue growth, might have raised concerns among investors about the company's profitability.
  • Overall, the market movement of QDEL today could be attributed to a combination of profit-taking after the earnings beat, concerns about margins, and broader sector trends affecting health care stocks.

14.00.2025 - QDEL Stock was down 7.0%

  • Despite solid preliminary fourth-quarter revenues meeting expectations, QDEL's stock experienced a bearish movement.
  • The market might have been expecting even higher revenues or growth projections, leading to a sell-off.
  • Investors could be concerned about future demand for COVID-19 testing products as vaccination rates increase, impacting QDEL's revenue potential.
  • The bearish movement could also be influenced by broader market trends or sector rotation, causing investors to reallocate their funds away from healthcare stocks like QDEL.

13.01.2025 - QDEL Stock was up 5.2%

  • QDEL surpassed estimates with its Q4 earnings and revenues, demonstrating robust financial performance.
  • The company's 14.55% earnings surprise and 0.79% revenue beat likely bolstered investor confidence in its growth prospects.
  • The strong results indicate high demand for QDEL's diagnostic healthcare solutions, potentially driving the positive stock movement.
  • Based on its strong financial performance and growth potential in the healthcare sector, investors may see QDEL as an appealing investment opportunity.

10.03.2025 - QDEL Stock was down 7.1%

  • The surge in QDEL's stock price might have been driven by the positive sentiment surrounding its strong product portfolio.
  • However, the bearish movement today could be attributed to profit-taking by investors after a significant surge.
  • The uncertainty regarding the stock's ability to sustain further gains due to the latest trend in earnings estimate revisions might have also contributed to the bearish movement.
  • Overall, while QDEL has shown growth potential, short-term fluctuations in the market sentiment and earnings outlook can lead to bearish movements like the one observed today.

11.06.2024 - QDEL Stock was up 5.8%

  • The bullish movement in QDEL stock could be attributed to the Carlyle Group entities selling over $2.5 million in QuidelOrtho shares.
  • This selling activity might have been perceived positively by investors as it could indicate confidence in the company's performance and future prospects.
  • The market may have interpreted this move as a strategic decision by Carlyle Group entities, potentially leading to increased investor interest and driving the stock price higher.

16.06.2024 - QDEL Stock was up 5.4%

  • Quidel experienced a strong bullish movement possibly due to positive market sentiment towards the healthcare sector.
  • The selling of over $2.5 million in QuidelOrtho shares by Carlyle Group entities might have initially caused some uncertainty in the market, but the stock managed to overcome this and surge upwards.
  • Mention of National Vision experiencing strength might have contributed to a positive outlook on the healthcare industry as a whole, benefiting Quidel's stock price.
  • Despite potential concerns about earnings estimate revisions for National Vision, investors may have viewed Quidel as a more promising investment option, leading to its notable increase in value.

23.06.2024 - QDEL Stock was up 5.0%

  • QuidelOrtho's strong product portfolio has raised optimism about the stock, contributing to its bullish movement today.
  • The news of Carlyle Group entities selling shares in QuidelOrtho worth over $5.7 million did not seem to have a significant negative impact on the stock's performance, indicating strong underlying bullish sentiment.
  • Investors seem to be focusing more on the positive aspects of QuidelOrtho's product portfolio rather than the selling of shares by Carlyle Group entities, driving the stock higher.

15.07.2024 - QDEL Stock was up 5.4%

  • Quidel Corporation (QDEL) experienced a strong bullish movement today.
  • Suggestions of potential activist campaigns and investigations by legal firms against Quidel Corporation have emerged.
  • Market sentiment could be influenced by the company's response to these challenges, demonstrating resilience and operational strength.
  • Investors may be optimistic about Quidel's prospects in handling legal issues, which could be driving the upward momentum in the stock price.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.